Abstract
We conducted a retrospective analysis to investigate the natural history and the clinical outcome after treatment of primary gastric lymphoma of T-cell origin. Seventeen cases of T-cell origin among 444 primary gastric lymphoma patients were analyzed. The median age of the 14 male and 3 female patients was 49 years (range 22-76 years). The median progression-free survival (PFS) and overall survival (OS) were only 10 months (95% CI; 0-20 months), and 12 months (95% CI; 4-21 months), respectively. This study showed that the incidence of this subtype of T-cell gastric lymphoma was very rare, and had poor prognosis.
MeSH terms
-
Adult
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Cyclophosphamide / administration & dosage
-
Disease-Free Survival
-
Doxorubicin / administration & dosage
-
Female
-
Humans
-
Lymphoma, T-Cell / drug therapy*
-
Lymphoma, T-Cell / mortality
-
Lymphoma, T-Cell / pathology*
-
Male
-
Middle Aged
-
Prednisone / administration & dosage
-
Retrospective Studies
-
Stomach Neoplasms / drug therapy*
-
Stomach Neoplasms / mortality
-
Stomach Neoplasms / pathology*
-
Survival Analysis
-
Time Factors
-
Vincristine / administration & dosage
Substances
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
Prednisone